GA 6: The Blood Glucose-lowering Effect of Glucose-dependent Insulinotropic Polypeptide

NCT03845179 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Type2 Diabetes

Interventions

OTHER: Placebo
OTHER: GIP receptor antagonist
DRUG: DPP-4 inhibitor
OTHER: Placebo tablet

Sponsor

University Hospital, Gentofte, Copenhagen